Literature DB >> 19124379

Pharmacotherapy for smoking cessation.

Laura Carrozzi1, Francesco Pistelli, Giovanni Viegi.   

Abstract

Tobacco dependence is a chronic relapsing disease that needs continuous treatment. In combination with behavioural support, pharmacotherapy is a proven key component for supporting smoking cessation. Effective drugs are available and recommended: nicotine replacement therapy (NRT), bupropion and varenicline. Much research into new pharmacological approaches is ongoing, combining 'old' and 'new' drugs and personalizing a pharmacological treatment for a single smoker/patient; other new medications and vaccines are in development. Overall, pharmacotherapy seems to have efficacy and cost-effectiveness in real life, thus physicians should become familiar with these medicines. Further efforts should be aimed at optimizing treatment management and increasing smoking cessation rates in the general population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19124379     DOI: 10.1177/1753465808096136

Source DB:  PubMed          Journal:  Ther Adv Respir Dis        ISSN: 1753-4658            Impact factor:   4.031


  10 in total

Review 1.  Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individuals.

Authors:  Raymond Niaura; Geetanjali Chander; Heidi Hutton; Cassandra Stanton
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

Review 2.  Nicotine vaccines to treat tobacco dependence.

Authors:  Maciej L Goniewicz; Marcin Delijewski
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

3.  The Smoking MUMS (Maternal Use of Medications and Safety) Study: protocol for a population-based cohort study using linked administrative data.

Authors:  Alys Havard; Louisa R Jorm; David Preen; Michael Daube; Anna Kemp; Kristjana Einarsdóttir; Deborah Randall; Duong Thuy Tran
Journal:  BMJ Open       Date:  2013-09-20       Impact factor: 2.692

4.  Preclinical Pharmacology, Efficacy and Safety of Varenicline in Smoking Cessation and Clinical Utility in High Risk Patients.

Authors:  Zheng-Xiong Xi
Journal:  Drug Healthc Patient Saf       Date:  2010-04-01

5.  Nicotine dependence and psychological distress: outcomes and clinical implications in smoking cessation.

Authors:  Fiammetta Cosci; Francesco Pistelli; Nicola Lazzarini; Laura Carrozzi
Journal:  Psychol Res Behav Manag       Date:  2011-09-12

6.  Pharmacologic agents for smoking cessation: a clinical review.

Authors:  Dilip R Patel; Cynthia Feucht; Lesley Reid; Neil D Patel
Journal:  Clin Pharmacol       Date:  2010-04-07

7.  Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokers.

Authors:  Peter H Silverstone; Rana Dadashova
Journal:  Ann Gen Psychiatry       Date:  2012-03-09       Impact factor: 3.455

8.  A pilot randomized trial examining the feasibility and acceptability of a culturally tailored and adherence-enhancing intervention for Latino smokers in the U.S.

Authors:  Marcel A de Dios; Miguel Ángel Cano; Ellen L Vaughan; Sarah D Childress; Morgan M McNeel; Laura M Harvey; Raymond S Niaura
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

9.  Life gain in Italian smokers who quit.

Authors:  Laura Carrozzi; Franco Falcone; Giulia Carreras; Francesco Pistelli; Giuseppe Gorini; Andrea Martini; Giovanni Viegi
Journal:  Int J Environ Res Public Health       Date:  2014-02-26       Impact factor: 3.390

10.  Algorithm for resolving discrepancies between claims for smoking cessation pharmacotherapies during pregnancy and smoking status in delivery records: The impact on estimates of utilisation.

Authors:  Lucinda Roper; Duong Thuy Tran; Kristjana Einarsdóttir; David B Preen; Alys Havard
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.